Literature DB >> 11544465

Markers of cell death-activation in lymphocytes of vertically HIV-infected children naive to highly active antiretroviral therapy: the role of age.

A Viganò1, M Pinti, M Nasi, L Moretti, F Balli, C Mussini, D Bricalli, N Sala, R Bugarini, S Vella, N Principi, A Cossarizza.   

Abstract

BACKGROUND: Apoptosis plays a major role in depleting CD4(+) lymphocytes during infection with HIV-1. Few data exist on its role during HIV infection of children. Sensitivity of peripheral blood lymphocytes (PBLs) to apoptotic stimuli and the importance of the patient's age remain unclear.
OBJECTIVES: We sought to analyze the following: (1) markers of cell death-activation (CD95, CD45 isoforms, and CD28) in PBLs from vertically HIV-infected children of different ages before highly active antiretroviral therapy; (2) changes in other PBL populations; (3) PBL sensitivity to cell death and mitochondrial damages; and (4) role of age during progression of infection.
METHODS: Cell culture techniques and flow cytometry were used to analyze surface antigens, PBL susceptibility to apoptosis, or PBL susceptibility to change of mitochondrial membrane potential.
RESULTS: Donor age had a strong negative correlation with numbers of CD4(+) and CD8(+) T cells. Virgin T lymphocyte (CD45RA(+), CD95(-)) levels and those of CD95(+) cells showed no correlation with the children's clinical status but did show a correlation with patient age. CD28(-) T lymphocytes were markedly augmented in HIV-infected children but were unrelated to stage of infection or age. A relevant decrease in B lymphocytes and an increase in natural killer cells were also found. Finally, PBLs from HIV-positive children had a marked tendency to undergo apoptosis and mitochondrial damage.
CONCLUSION: Changes in PBL phenotype, increased expression of CD95, and high sensitivity to apoptosis suggest that a precocious aging of the immune system occurs in HIV-infected children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544465     DOI: 10.1067/mai.2001.117791

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

1.  Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.

Authors:  Patrícia A Brindeiro; Rodrigo M Brindeiro; Cláudio Mortensen; Kurt Hertogs; Veronique De Vroey; Norma P M Rubini; Fernando S Sion; Carlos A M De Sá; Deisy M Machado; Regina C M Succi; Amilcar Tanuri
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 2.  Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms.

Authors:  Elena Chiappini; Martina Bianconi; Annalisa Dalzini; Maria Raffaella Petrara; Luisa Galli; Carlo Giaquinto; Anita De Rossi
Journal:  Aging (Albany NY)       Date:  2018-11-11       Impact factor: 5.682

Review 3.  Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy.

Authors:  Michellie Thurman; Samuel Johnson; Arpan Acharya; Suresh Pallikkuth; Mohan Mahesh; Siddappa N Byrareddy
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

4.  Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.

Authors:  Suvercha Bhardwaj; Fareed Ahmad; Heiner Wedemeyer; Marcus Cornberg; Julian Schulze Zur Wiesch; Jan van Lunzen; Shiv K Sarin; Reinhold E Schmidt; Dirk Meyer-Olson
Journal:  Virol J       Date:  2016-04-18       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.